Trans-(1S,4R)-4-(6-amino-2-fluoropurin-9-yl)-2,3-dihydroxy-N,1-dimethylcyclopentane-1-carboxamide
C13H17FN6O3 — CID 174067120
Data last refreshed: (MolForge compound catalog, from PubChem)
About Trans-(1S,4R)-4-(6-amino-2-fluoropurin-9-yl)-2,3-dihydroxy-N,1-dimethylcyclopentane-1-carboxamide
Trans-(1S,4R)-4-(6-amino-2-fluoropurin-9-yl)-2,3-dihydroxy-N,1-dimethylcyclopentane-1-carboxamide (PubChem CID 174067120) has the molecular formula C13H17FN6O3 and a molecular weight of 324.32 g/mol. Its IUPAC name is trans-(1S,4R)-4-(6-amino-2-fluoropurin-9-yl)-2,3-dihydroxy-N,1-dimethylcyclopentane-1-carboxamide.
Molecular Properties
| Compound Name | Trans-(1S,4R)-4-(6-amino-2-fluoropurin-9-yl)-2,3-dihydroxy-N,1-dimethylcyclopentane-1-carboxamide |
|---|---|
| PubChem CID | 174067120 |
| Molecular Formula | C13H17FN6O3 |
| Molecular Weight | 324.32 g/mol |
| Exact Mass | 324.13 |
| IUPAC Name | trans-(1S,4R)-4-(6-amino-2-fluoropurin-9-yl)-2,3-dihydroxy-N,1-dimethylcyclopentane-1-carboxamide |
| SMILES | CNC(=O)[C@@]1(C)C[C@@H](n2cnc3c(N)nc(F)nc32)C(O)C1O |
| InChI | InChI=1S/C13H17FN6O3/c1-13(11(23)16-2)3-5(7(21)8(13)22)20-4-17-6-9(15)18-12(14)19-10(6)20/h4-5,7-8,21-22H,3H2,1-2H3,(H,16,23)(H2,15,18,19)/t5-,7?,8?,13+/m1/s1 |
| InChIKey | XTCMABAKMAEGMV-IMMMJNSESA-N |
| XLogP | -1.03 |
| TPSA | 139.18 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 324.32 |
| LogP ≤ 5 | -1.03 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174067120 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.